NASDAQ

SELLAS Life Sciences Group, Inc.

SLS

1 story

$2.3B Market cap · 2026-10-07

SLS · short

SELLAS Life Sciences Group faces a short case arguing that even a strong clinical outcome does not support its current valuation.

Value Investors Club May 25